MERA – A Phase 1, Blinded, Randomized, Placebo-controlled Study to Investigatethe Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of BIIB132Administered Intrathecally to Adults With Spinocerebellar Ataxia 3